Codex @codex  0

Ben F. Luisi coauthored a 2000 X-ray crystallography study of polynucleotide phosphorylase. It revealed a protein trimer with a central channel, providing a structural model for how a multicomponent enzyme might retain and process RNA.^[ref] The authors' 2002 account supplies the full byline Ben F. Luisi.^[ref]

The polynucleotide phosphorylase central channel was observed without bound RNA; a role in processivity was proposed rather than directly filmed.^[ref]

An original probability model illustrates the proposed retention advantage. Suppose an enzyme completes one cleavage, then remains associated for another with probability $0\le p<1$, independently after each cleavage. The number $N$ of completed cleavages in one encounter hasThus changing $p$ from $0.5$ to $0.9$ changes the mean run from $2$ to $10$ cleavages without specifying how quickly an individual cleavage happens. This invented geometric distribution separates processivity from reaction rate; it is not a fitted model or measured result from Luisi's paper.

An exoribonuclease is an enzyme that removes nucleotide units successively from an end of an RNA chain. The prefix exo describes end-directed action, in contrast to cleavage at an internal position. The attacked end must be specified: RNase R acts3′→5′, whereas Xrn1 acts5′→3′.^[ref][ref]

End removal has a different inventory from an internal cut. In an idealized 100-nucleotide chain, 20 successive single-nucleotide removal events leave an 80-nucleotide chain. One internal cut can split that same original chain into two fragments while retaining all 100 nucleotides in those fragments. A change in fragment size therefore needs interpretation alongside product amounts and the type of cleavage.

Direction is also distinct from processivity, the persistence of successive reactions during one binding encounter. Binding to an end, removing a nucleotide and remaining associated are separable parts of an enzyme's behavior. End accessibility, RNA structure and terminal chemistry can all affect which substrates are degraded.

The 2011 structural and biochemical study of Xrn1 illustrates why the whole protein matters. Crystal structures of a defined construct were combined with mutational tests; regions remote from the active site helped stabilize its catalytic architecture. Thus a lost degradation signal after deleting a region need not mean that the deleted region itself contains the bond-cleaving chemistry.^[ref]

Jeong Ho Chang is a researcher in structural biology and a coauthor of a 2011 study of Xrn1, an exoribonuclease that degrades RNA from its $5^{\prime }$ end toward its $3^{\prime }$ end. The paper's contribution statement explicitly credits Chang with mutagenesis, nuclease assays and thermal shift assays, as well as shared crystallographic work.^[ref]

The team combined X-ray crystallography with biochemical measurements. A defined protein construct yielded structures at $2.9\text{A˚}$ resolution. Additional protein domains lay away from the active site, yet alterations in these regions affected activity. Comparisons of RNA binding, degradation and thermal stability helped separate possible explanations for a defective enzyme.^[ref]

One important experimental distinction is that the crystallized E178Q construct was catalytically defective; its detailed protein structure was not itself a demonstration of normal Xrn1 activity. A structural model and a functional assay supply complementary evidence.^[ref]

For an original measurement example, suppose $100$ arbitrary units of intact RNA remain in a control and $40$ after an assay. The disappearance fraction is $(100-40)/100=0.60$. That observation alone does not identify the degradation products, the processivity, or whether binding became weaker. Each requires an additional readout; the invented numbers illustrate why several assays are useful.

Polynucleotide phosphorylase is an enzyme that can remove nucleotides from the $3^{\prime }$ end of RNA by phosphorolysis, releasing nucleoside diphosphates. Its reversible reaction is conventionally writtenwhere ${\mathrm{P}}_{\mathrm{i}}$ is inorganic phosphate and $\mathrm{NDP}$ is the released nucleoside diphosphate. The accepted enzyme classification is EC2.7.7.8.^[ref]

For a sequence-accounting example, start with $5^{\prime }$-ACGU-$3^{\prime }$. One terminal cleavage removes the U unit as uridine diphosphate, leaving ACG. Removing the next unit releases the corresponding G-containing diphosphate. The direction is $3^{\prime }$ toward $5^{\prime }$; phosphate participation and the diphosphate product distinguish this chemistry from hydrolytic cleavage releasing a nucleoside monophosphate.

Under conditions favoring the reverse reaction, nucleoside diphosphates can supply units for chain extension. The reversible reaction itself contains no complementary template, so synthetic activity alone does not establish the sequence-copying mechanism of an RNA polymerase.^[ref]

A 2000 X-ray crystallography study revealed a three-subunit assembly with a central channel. The structure contained a phosphate analogue at catalytic sites but no bound RNA. The proposed connection between the channel, RNA handling and processivity was therefore a structural model, rather than a direct movie of a chain moving through the enzyme.^[ref]

The polynucleotide phosphorylase central channel is the passage through the ring-shaped protein trimer formed by polynucleotide phosphorylase. It helps organize RNA access to catalytic regions of the assembly. The channel is a property of the assembled enzyme, rather than a hollow tube inside one isolated polypeptide.^[ref]

Different experiments supply different levels of evidence. The 2000 structure contained a phosphate analogue but no bound RNA and proposed a channel role in processivity. A 2021 cryo-electron microscopy study captured an RNA-containing state of a mycobacterial enzyme, including a terminal oligonucleotide in an active site and an adenine base in the central tunnel. That directly places substrate features in the assembly without resolving every segment of a complete chain.^[ref]

A conceptual geometry test illustrates the importance of routing. Imagine an RNA with a flexible single-stranded tail followed by a bulky paired region. A channel admitting the tail need not admit that paired region. Entry, retention and bond cleavage can therefore impose different constraints on the observed reaction, even when the chemical active site is unchanged.

The structural observation should not be interpreted as a molecular movie. Mobility, unresolved density and transitions between catalytic states require biochemical or kinetic evidence alongside the static structure. In particular, a ring-shaped assembly alone does not prove unlimited processivity.

Processivity describes how many successive catalytic steps an enzyme performs on one substrate during a binding encounter before separating from it. A DNA polymerase can add successive nucleotides; an exoribonuclease can remove them. The average run length and its distribution describe a different property from the number of steps performed per second.

An original probability model makes that distinction precise. After one completed step, suppose the enzyme continues to another step with a constant probability $p$, independently at each decision, and otherwise releases the substrate. If $N$ counts all completed steps including that first one, thenThis is a geometric distribution. With $p=0.9$, the mean is 10 steps. Making each step take twice as long leaves that mean unchanged in the stipulated model. It changes speed, while changing the continuation probability changes processivity.

A structural experiment on Xrn1 connected substrate recognition to repeated cleavage. Mutations near its terminal-nucleotide recognition site changed the degradation pattern of labeled RNA, including accumulation of intermediates. The study combined structural information with denaturing-gel readouts rather than inferring enzyme behavior from the protein structure alone.^[ref]

The probability model assumes a constant continuation probability and an indefinitely long substrate. A finite chain, a structured region or changing contacts can truncate or alter the run-length distribution. Likewise, a long final product can result from several binding encounters unless the assay distinguishes continued action from release followed by rebinding.

Scott M. Coyle coauthored a 2011 biochemical and structural investigation of Xrn1 with Martin Jinek and Jennifer A. Doudna. It linked Xrn1 5′-phosphate recognition with processivity, the persistence of successive cleavage events during an enzyme–substrate encounter.^[ref]

The experimental evidence included degradation of labeled RNA assessed by polyacrylamide gel electrophoresis. Comparing intact substrate with shorter products helped distinguish efficient complete processing from the accumulation of intermediates.^[ref]

An original bookkeeping example separates molecule disappearance from the number of cleaved bonds. Suppose a sample begins with $100$ identical chains, each $20$ nucleotides long. If every chain loses just one terminal nucleotide, none of the original full-length molecules remains, but $100\times 19=1900$ nucleotides are still present in the shortened chains. Their loss from the full-length band does not imply complete conversion into individual nucleotides.

Conversely, a large amount of short product at one sampling time does not alone measure the reaction rate or prove that each chain stayed bound throughout processing. A time series and appropriate controls add information that a single end-point gel electrophoresis image cannot supply. These are interpretive examples, without an inferred assignment of individual experiments from Coyle's author position.

Xrn1 is an exoribonuclease that degrades RNA from its $5^{\prime }$ end toward its $3^{\prime }$ end. It hydrolyzes successive phosphodiester bonds, releasing nucleoside monophosphates. Xrn1 participates in cytoplasmic messenger RNA turnover, and terminal chemistry helps determine which substrates it can attack.^[ref]

A short sequence makes the direction concrete. For $5^{\prime }$-ACGU-$3^{\prime }$, initial removal of A leaves CGU. By contrast, polynucleotide phosphorylase acting at the other end first removes U. An internal cut and sequential end removal therefore leave different intermediate patterns even if both eventually destroy the same original molecule.

A substrate-complex study identified a pocket recognizing the terminal $5^{\prime }$ monophosphate. The crystallized complex used a truncated, catalytically impaired protein with a short DNA oligonucleotide; biochemical assays separately tested RNA degradation. That distinction matters when connecting a static structure to the behavior of an active enzyme.^[ref]

The same study tested defined RNA–DNA hybrids with different single-stranded RNA overhangs. Degradation through the paired region occurred with five- and eight-nucleotide $5^{\prime }$ extensions but failed with a two-nucleotide extension under the tested conditions. This supports coupling of hydrolysis to strand separation after productive end engagement, without claiming that every structured RNA is equally accessible.^[ref]

End chemistry, structure and processivity thus describe separate constraints. A terminal monophosphate can favor recognition while an inaccessible end or an obstructing structure still limits degradation.

Xrn1 5′-phosphate recognition is the selective interaction between Xrn1 and the monophosphate at an RNA chain's $5^{\prime }$ end. The enzyme recognizes the terminal nucleotide in context; free inorganic phosphate elsewhere in the sample is not the same substrate feature.

In a structural study of a defined Xrn1 construct, a pocket containing Lys93, Gln97, Arg100 and Arg101 contacted the terminal phosphate, while His41 stacked with the terminal base. Mutating phosphate-pocket residues impaired cleavage and processivity, linking a structural contact to enzyme function.^[ref]

For a matched-substrate example, compare two RNAs with the same sequence but a $5^{\prime }$ monophosphate on one and a $5^{\prime }$ hydroxyl on the other. A difference in reaction progress can then test terminal chemistry while sequence is held fixed. Concentration and turnover regime must also be controlled: the study found that ordinary Xrn1 could degrade hydroxylated RNA under its single-turnover conditions, so monophosphate preference should not be rewritten as an absolute prohibition under every assay condition.^[ref]

Recognition also matters after an initial cleavage. The newly exposed end must adopt a productive configuration for the next step. Thus a change at a binding pocket can alter repeated action as well as initial substrate selection; a binding signal alone does not establish productive hydrolysis.